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Objectives: Treatment of venous ulcers is demanding for patients as
well as clinicians, and treatment of underlying venous hypertension is the
cornerstone of therapy. We propose that iliac vein angioplasty and stenting
(IVAS) augment healing of venous ulcers in selected patients.
Methods: We conducted a retrospective review of all prospectively
collected data from patients with CEAP 6 venous disease. Patient demo-
graphics, comorbidities, venous reﬂux studies, and ulcer description were
analyzed. Iliac vein stenosis was deﬁned as $50% stenosis on intravascular
ultrasound. All patients had great saphenous vein ablation, in addition to
conservative treatment, including Unna boot compression, and perforator
closure using ablation therapy.
Results: Seventeen patients with CEAP 6 venous disease and ulcers
greater than 1.5 cm in diameter were included. The average age was 63
6 10 years of age, and the majority were female (70.6%) with common
comorbidities such as hyperlipidemia (47.1%), hypertension (35.3%) and
diabetes (23.5%). All patients had arterial duplex evaluations to rule out
associated peripheral vascular disease. Twenty-four ulcers with an average
diameter of 3.1 6 0.9 cm and depth 2.2 6 0.5 cm were treated. Perforator
venous reﬂux was 3.66 0.8 seconds with diameter estimated at 3.76 2 mm
performed in an accredited vascular laboratory. The majority (n ¼ 15;
62.5%) of the perforator veins were located at the base of the ulcer, whereas
the remainder (n ¼ 9; 32.5%) were within 2 cm from the base. Seven
(29.2%) of the 24 ulcers did not respond to the conventional therapy; all
were found to have signiﬁcant iliac vein stenosis and were treated with
IVAS. Ulcer healing time was shorter in IVAS group (3.9 6 1.5 weeks)
than those patients receiving only perforator and Unna boot treatment
(7.9 6 9.2 weeks), although this difference was not statistically signiﬁcant
(P ¼ .223), which was directly attributed to sample size. Two patients,
one in each group, experienced ulcer recurrence (P ¼ .507).
Conclusions: The early results from this study suggest that venous
ulcer healing can be augmented with iliac vein angioplasty/stenting. The
majority of underlying perforators were found under or within 2 cm from
the venous ulcer. However, our early results should be viewed with caution
because of the small sample size. Further studies are needed to deﬁne the
exact role of iliac vein angioplasty/stenting in patients with venous ulcers.
Aromatase Deletion Accelerates Female Experimental Abdominal
Aortic Aneurysm Formation
William Forrest Johnston, Gang Su, Morgan Salmon, Guanyi Lu, Emilie F.
Rissman, Gorav Ailawadi, Gilbert Rivers Upchurch Jr. University of
Virginia, Charlottesville, Va
Objectives: The protective effects of female sex on the development
of abdominal aortic aneurysms (AAAs) have been attributed to the anti-
inﬂammatory effects of estrogen. All estrogen synthesis depends on the
enzyme aromatase, which is located centrally in the ovaries, as well as
peripherally in adipose tissue, bone, and vascular smooth muscle cells. We
hypothesized that aromatase genetic deletion would diminish the protective
effect of female sex and would be associated with increased aortic diameter
in female mice.
Methods: Female 8- to 10-week-old mice with aromatase (wild type:
WT) and without aromatase (ArKO) underwent elastase aortic perfusion.
WT male mice underwent elastase perfusion as a positive control. To eval-
uate the contribution of peripheral estrogen conversion, female WT and
ArKO mice that had undergone ovariectomy (ovx) at 6 weeks were perfused
with elastase. Thus, four groups of female mice were compared: WT, ArKO,
WT ovx, and ArKO ovx. At aortic harvest, maximal aortic dilations, aortic
inﬂammatory cytokines, and serum estradiol concentrations were compared
with analysis of variance.
Results: Female WT mice had signiﬁcant reduction in aortic dilation
compared with male WT mice (F WT: 51.15.9% vs M WT: 79.3 1.6%; P <
.005). The protective effects of female sex were mostly overcome with ovari-
ectomy (WT ovx: 70.64.1%; P < .05 vs F WT) and completely eliminated
with deletion of aromatase (ArKO: 78.57.8%; P < .05 vs F WT). Peripheral
estrogen conversion accounted for 30% of the protective effect of female sex.
Female mice with both aromatase deletion and ovariectomy had the largest
aortic dilation (87.35.6%; P < .001 vs F WT and P < .05 vs WT ovx).
Concordantly, female ArKO ovx mice had signiﬁcantly higher levels of proin-
ﬂammatory cytokines Monocyte chemotactic protein-1 and interleukin-1. As
expected, deletion of aromatase or ovariectomy was associated with
decreased serum estradiol levels with a direct correlation between decreasing
estradiol levels and increasing aortic dilation (R ¼ 0.465; P < .05).
